Minireviews
Copyright ©The Author(s) 2023.
World J Clin Cases. May 6, 2023; 11(13): 2890-2902
Published online May 6, 2023. doi: 10.12998/wjcc.v11.i13.2890
Figure 1
Figure 1 Individualised diabetes care - graphical abstract. GLP-RA; SGLT2 inhibitor.
Figure 2
Figure 2 Vicious cycle of insulin resistance and weight gain.
Figure 3
Figure 3 Gut glucagon-like peptide, gastric inhibitory peptide and glucagon system and its pharmacological analogues. GLP: Gut glucagon-like peptide; GIP: Gastric inhibitory peptide; GLP-1RA: Glucagon-like peptide-1 receptor agonist.